San Francisco, CA, United States of America

Marina Gelman

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Marina Gelman

Introduction: Marina Gelman, based in San Francisco, CA, is a prolific inventor with 17 patents to her name. She has made significant advancements in the field of pharmaceutical compositions, particularly with TGF-β inhibitors. Her inventions showcase her dedication to innovation and her passion for improving healthcare through science.

Latest Patents: Among her latest patents, Gelman has disclosed novel pyrazole compounds that serve as TGF-β inhibitors. These compounds have potential pharmaceutical compositions and methods of use that inhibit the activity of members of the TGF-β superfamily, which can be instrumental in treating various diseases. The detailed structure includes pharmaceutically acceptable salts, prodrugs, N-oxides, and their solvates and hydrates, indicating the comprehensive nature of her work in this complex area of medicinal chemistry.

Career Highlights: Throughout her career, Marina Gelman has worked with reputable companies such as Rigel Pharmaceuticals, Incorporated and Bristol-Myers Squibb Company. Her roles in these organizations have allowed her to contribute significantly to the pharmaceutical industry and facilitate advancements in innovative treatments.

Collaborations: Gelman's collaborative efforts have also been noteworthy. She has worked alongside esteemed colleagues such as Rajinder Paul Singh and Todd M. Kinsella. Their teamwork has undoubtedly fostered a creative environment leading to breakthroughs in their respective fields.

Conclusion: Marina Gelman represents a remarkable example of ingenuity and scientific inquiry in the realm of pharmaceuticals. With her extensive patent portfolio and collaborative spirit, she continues to push the boundaries of innovation and contribute meaningfully to medical science. Her work with TGF-β inhibitors stands as a testament to her commitment to developing effective therapies that could transform the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…